Corporate News – Coloplast (COLO-B.CO)
Coloplast A/S shares finished the trading session at DKK 476.00 on the OMX Nordic Exchange Copenhagen, down 1.12 % from the previous close. The decline occurred during a 24‑hour period ending at 08:28 PM Central Europe on Tuesday 20 October 2026.
Market Metrics
| Item | Value |
|---|---|
| Current price | DKK 476.00 |
| Trading volume (last 24 h) | DKK 99 million |
| Shares outstanding | 225.2 million |
| Market capitalisation | DKK 105.4 billion |
| Simple moving average (200 days) | DKK 442.58 |
| 52‑week high | DKK 631.40 (05 Nov 2025) |
| 52‑week low | DKK 369.70 (18 Jun 2026) |
| Year‑to‑date change | +11.03 % (since month‑end) |
Analyst Commentary
- Handelsbanken (Sweden) has raised its target price to DKK 480 and maintains a neutral buy recommendation.
- SEB (Sweden) has increased its target to DKK 515 while also recommending a buy stance.
- The stock is among the top shorted equities in Denmark, with a net short exposure of approximately 3.6 %.
- Analysts view the updated targets as reflecting cautious optimism, noting limited upside potential in a market rotating away from technology themes toward defensive sectors.
- No new earnings data or operational updates were disclosed in the latest filings.
Context: Related Danish Stocks
| Stock | Recent Move | Current Price | Market Cap | P/E Ratio | Recent News |
|---|---|---|---|---|---|
| Jyske Bank (JYSK.CO) | Down 1.4 % | DKK 1,049 | DKK 59 bn | 12.42 | Regulatory approval to acquire FP Kapital A/S; transaction effective 2 Nov 2026. |
| Al Sydbank (ALSYDB.CO) | Down 0.49 % | DKK 705 | DKK 59.8 bn | 20.94 | Share‑buyback programme continues; 30,000 shares acquired this week. |
| Tryg A/ (TRYG.CO) | Up 0.39 % | DKK 155.4 | DKK 91.4 bn | 19.75 | No new corporate actions reported. |
| Alk‑Abello A/ (ALK-B.CO) | Up 4.22 % | DKK 237.8 | DKK 52.6 bn | 38.24 | Net short exposure ~0.3 %; no immediate corporate actions. |
| Demant A/ (DEMANT.CO) | Up 0.28 % | DKK 362 | DKK 75.6 bn | 31.05 | Appointment of Bassel Rifai as director of the wholesale segment; modest net short exposure. |
Company Overview
Coloplast A/S is a global health‑care equipment and supply company headquartered in Humlebaek, Denmark. The firm develops and markets intimate health‑care products and services across three primary segments:
- Chronic Care – products for long‑term conditions.
- Interventional Urology – devices and therapies for urological conditions.
- Wound & Skin Care – solutions for wound management and skin protection.
Coloplast is listed on the OMX Nordic Exchange Copenhagen AS. Further information is available on the company’s website at www.coloplast.com .
